Faculty Information - Kikuchi Noriko

（Last updated : 2024-04-11 11:24:23）

Kikuchi Noriko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Cardiology

Position Assistant Professor

■ Published papers

1.	Original article	Increased Left Ventricular End-Diastolic Volume Index Is Associated With Increased Adverse Events After MitraClip Implantation. 2024/01/15
2.	Case report	Early recurrence of myocarditis with atrioventricular block while wearing a wearable cardioverterdefibrillator after fulminant myocarditis: A case report 2023/05
3.	Original article	Clinical Validation of a Neointima-Inducing Inflow Cannula in a Continuous Flow Left Ventricular Assist Device. 2023/03
4.	Original article	Stratification of Destination Therapy Candidates by J-HeartMate Risk Score Among Elderly Non-Responders to Cardiac Resynchronization Therapy. 2022/08/26
5.	Original article	Ventricular Assist Device-Induced Ventricular Septal Perforation. 2022/07/25
6.	Original article	Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates. 2022/04
7.	Case report	Acute myocardial infarction and sudden cardiac arrest caused by anomalous left coronary artery arising from the noncoronary cusp 2022/01/03
8.	Original article	Impact of anatomical position of the inflow cannula on stroke in patients with left ventricular assist devices 2022/01
9.	Case report	Use of Three-Dimensional Computed Tomography to Image Archived Fatty Tissue of Arrhythmogenic Cardiomyopathy 2021/09/24
10.	Case report	Characteristics of Left-Dominant Arrhythmogenic Cardiomyopathy 2021
11.	Case report	Heart transplant candidate with medical complexity in the era of prolonged left ventricular assist device support — A case report 2020/10/22
12.	Original article	Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease. 2020/05
13.	Case report	An Autopsy Case of Arrhythmogenic Right Ventricular Cardiomyopathy　- Radiological/Pathological Comparison. 2020/04
14.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
15.	Original article	Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease. 2016/05
16.	Case report	Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. 2016/04
17.	Original article	Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/02
18.	Other	Pitavastatin Prevents Atherosclerotic Plaque Development via Inhibition of TRAIL Expression on CD4 T Cells 2010
19.	Other	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow up at a Tertiary Hospital in Japan 2010
20.	Other	Role of PSGL-1 Expressing CD4 T Cells in Acute Coronary Syndrome 2010
Display 5 items
Display all(20)

■ Academic conference presentation

1.	D-dimer Levels Predict Mortality in Patients with Temporary Mechanical Circulatory Support 2024/03/10
2.	Hub and Spoke Model of Cardiogenic Shock Patients: The Role of Hub Hospital 2024/03/09
3.	The Possibility of Destination Therapy for Elderly Non-responder of Cardiac Resynchronization Therapy 2021/03/29
4.	Clinical Features of Deteriorating Cardiogenic Shock Patients 2021/03/28
5.	Characteristics of Advanced Heart Failure Patients Candidate to Ventricular Assist Devices as Destination Therapy 2021/03/26
6.	Factors Associated With Ejection Fraction Improvement Among Hospitalized Heart Failure Patients With Reduced Ejection Fraction 2019/11/17
7.	A case of chronic thromboembolic pulmonary hypertension in systemic sclerosis 2019/10/05
8.	A case with ischemic severe heart failure improved temporary after Autologous myoblast sheets transplantation therapy, but we could not save 2019/10/04
9.	Changes of ejection fraction among hospitalized heart failure patients: From HIJ-HFII study 2019/10/04
10.	Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study 2019/09/02
11.	Myocardial flow reserve using 13N ammonia PET for detection of cardiac allograft vasculopathy in heart transplant patients 2019/09/02
12.	Incidence and Predictors of Long-term Renal Function Deterioration after Implantation of a Centrifugal, Continuous-flow Device for Bridge to Transplant 2019/04/05
13.	Myocardial Flow Reserve Using 13N Ammonia PET for Detection of Cardiac Allograft Vasculopathy 2019/04/03
14.	Usefulness of Wearable Cardioverter Defibrillator as a Bridge Therapy 2019/03/31
15.	13N Ammonia PET Myocardial Flow Reserve for Detection of Cardiac Allograft Vasculopathy in Heart Transplant Patients 2019/03/30
16.	Management of Ventricular Arrhythmias in Patients with Implanted Ventricular Assist Devices 2019/03/30
17.	Prognostic Impact of Discharge Serum Chloride Levels in Heart Failure Patients: An Analysis of HIJ-HF II Multicenter Cohort Study 2019/03/30
18.	Renal Function and the Prognostic Impact of Renin-angiotensin-aldosterone System Inhibitors for Heart Failure Patients: An Analysis of HIJ-HF II Study 2019/03/29
19.	A new treatment option with ipragliflozin administered additionally in a caseinvolving stage D heart failure with diabetes 2018/10/13
20.	Treatment strategy for Cpc-PH after surgery of mitral valve disease; Insights from a case report 2018/10/13
21.	Cardiac Resynchronization Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia: Case Reports and Clinical Implications 2018/10/11
22.	Impact of congestion in worsening renal failure after implantation of a centrifugal, continuous-flow left ventricular device 2018/08/27
23.	Temporal trends in clinical characteristics, management of heart failure patients with mid-range ejection fraction in Japan: from the HIJ-HF studies 2018/05/26
24.	Use of mineralocorticoid receptor antagonists in real-world patients with nonischemic heart failure and reduced ejection fraction: an analysis of HIJ-HF II study 2018/05/26
25.	Long-Term Changes in Renal Function after Implantation of a Centrifugal-type, Continuous-flow Left Ventricular Assist Device 2018/03/25
26.	Use of Mineralocorticoid Receptor Antagonists in Real-world Heart Failure Patients with Reduced Ejection Fraction: An Analysis of HIJ-HF II Study 2018/03/25
27.	Heterozygous Familial Hypercholesterolemia: Insight into Polygenetic Abnormalities in Japanese Patients 2018/03/24
28.	Importance of physiological pacing on right heart failure in a case with left ventricular noncompaction and left ventricular assist device 2017/10/13
29.	Long-term changes in renal function in patients after implantation of a centrifugal-type, continuous-flow left ventricular assist device 2017/10/13
30.	Effectiveness of sildenafil for right ventricular failure after left ventricular assisted device implantation: a case report 2017/10/12
31.	Successful withdrawal of implantable left ventricular assist device in a case with major cerebrovascular complication 2017/10/12
32.	Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction 2017/08/29
33.	Heart Team Approach for LVAD - Cooperation with Home Medical Care - 2017/03/19
34.	Recovery of Left Ventricular Ejection Fraction and Ventricular Arrhythmias in Heart Failure Patients: Prospects of Wearable Cardioverter Defibrillator 2017/03/19
35.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure 2017/03/18
36.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Japanese Heart Failure Patients: From the HIJ-HF Cohort Study 2017/03/18
37.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study 2017/03/17
38.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction 2017/03/17
39.	Beta-blockers and Prognosis in Patients with Atrial Fibrillation and Heart Failure: From the HIJ-HF Cohort 2016/10/09
40.	A Case of Dilated Cardiomyopathy Demonstrating Markedly Improvement from Deteriorated Renal Function by Challenging Catecholamine Infusion and Succeeding an Implantable-VAD 2016/10/08
41.	Short-term Prevalence of Fatal Ventricular Arrhythmic Event in Patients with Newly-diagnosed Reduced Ejection Fraction 2016/10/08
42.	Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure with Preserved Ejection Fraction: From the HIJ-HF cohort study 2016/10/07
43.	The prognostic and therapeutic target role of atrial tachyarrhytmia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2016/07/16
44.	Prognostic Role of Atrial Tachyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasi 2016/03/19
45.	The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis 2015/10/22
46.	Prognostic Significance of Myocardial Fibrosis Detected by Magnetic Resonance Imaging in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 2015/04/26
47.	Atrial Arrhythmia is a Marker of Disease Progression in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2015/04/24
48.	Clinical Phases Vary with Disease Stage in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2015/04/24
49.	PSGL-1 expressing CD4 T cells in plaque instability 2011/08
50.	Impact of Pulmonary Artery Pressure and Transpulmonary gradient on Long-term Outcome in Dilated Cardiomyopathy Patients with Pulmonary Hypertension 2011/03/20
51.	Clinical Phases Vary with Time Course in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 2011/03/19
52.	Prognostic Implications of Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Long Term Follow Up at a Tertiary Hospital in Japan 2011/03/19
53.	The Model for End-Stage Liver Disease Score as an Independent Predictor of Outcomes in Cardiac Resynchronization Therapy 2011/03/18
54.	The role of PSGL-1-expressing CD4 T cells in perimenopausal women 2010/07
Display 5 items
Display all(54)

■ Education

1.		Faculty of Medicine, Tokyo Women's Medical University, Graduated,
2.	Degree Acquisition	Tokyo Women's Medical University,